John P. Sharp
John Sharp is a seasoned finance executive with more than 30 years of experience in financial and business planning and currently serves as a Senior Director at Lohman & Associates. He has served as Chief Financial Officer for several biopharmaceutical companies since April 2007. He has been Chief Financial Officer of Skye Bioscience, Inc. since […]
James Ferguson, M.D., FACC, FAHA
James Ferguson is a distinguished medical expert with over 25 years of leadership in the cardiovascular field and deep expertise in clinical development. Dr. Ferguson joined Cadrenal in February 2025 from Matinas BioPharma where he served as Chief Medical Officer. Previously, Dr. Ferguson served as Head of U.S. Cardiovascular Medical Affairs at Amgen and held […]
Jeff Cole
Jeff Cole has served as our Chief Operating Officer since February 2024 and brings over 25 years of experience in global pharmaceutical manufacturing, commercial operations, finance, and corporate development. Prior to that, Mr. Cole provided operational and financial advisory services to the Company in his capacity as Principal of J. Scott Capital, a firm he […]
Quang Pham
Quang Pham has served as our Chief Executive Officer since he formed the Company. He previously served as Chairman & CEO of Espero BioPharma, Inc., a company he also founded and the previous sponsor of the tecarfarin IND. He then served as a consultant to HESP LLC, the assignee for Espero to Horizon Technology Finance. […]